FDC Ltd Faces Continued Challenges Amid Significant Stock Volatility and Underperformance
FDC Ltd, a midcap pharmaceutical company, has reached a new 52-week low amid significant volatility, underperforming its sector. The stock has faced consecutive losses over four days and is trading below key moving averages, reflecting ongoing challenges. Over the past year, FDC has declined notably compared to the Sensex.
FDC Ltd, a midcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, reaching a new 52-week low of Rs. 388.2. This decline marks a notable underperformance, as the stock has lagged behind its sector by 2.07%. Over the past four days, FDC has faced consecutive losses, accumulating a total decline of 4.82%.Today's trading saw the stock hit an intraday low of Rs. 388.2, reflecting a decrease of 2.95% at its lowest point. Additionally, FDC is currently trading below its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a challenging market position.
In terms of longer-term performance, FDC Ltd has seen a decline of 14.97% over the past year, contrasting sharply with the Sensex, which has gained 2.08% during the same period. These metrics highlight the ongoing challenges faced by FDC in the current market landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
